Medicaid spending on pathology and lab procedures in Orange climbed to $149,334 in 2024

Dr. Mehmet Oz CMS Administrator
Dr. Mehmet Oz CMS Administrator
0Comments

Orange Medicaid providers billed a total of $149,334 in 2024 for Pathology and Laboratory Procedures, as detailed in the U.S. Department of Health and Human Services Medicaid Provider Spending database. This figure represents a 21% rise from 2023, when $123,414 was billed for the same services.

Medicaid is a state-run public health insurance program funded in partnership by federal and state governments. The program covers low-income individuals, families, seniors, children, and those with disabilities, making it a key part of the U.S. health care landscape.

Trends in local Medicaid billing demonstrate how taxpayer-funded health care dollars are distributed in communities.

The Pathology and Laboratory Procedures category encompasses a set of Medicaid services grouped by the kind of care delivered, relying on standardized HCPCS and CPT code classifications. For this report, each billing code was included in a specific service category according to code prefixes and number ranges to ensure services are grouped accurately, prevent double counting, and maintain reliable rankings over time.

Although spending was up across several service areas, Pathology and Laboratory Procedures ranked third among all Medicaid payment categories in Orange for 2024.

Statewide, Pathology and Laboratory Procedures were the sixth-highest category by Medicaid payments in Texas during 2024.

From 2019 through 2024, Medicaid payments for Pathology and Laboratory Procedures in Orange grew by $131,229, representing a 724.8% increase. Notable annual increases were observed in 2021 and 2022.

Payments for services in this category were distributed throughout Orange but were heavily concentrated in certain ZIP codes. In 2024, ZIP code 77630 made up the full $149,334 billed, accounting for 100% of Medicaid spending in this category in Orange.

Within Pathology and Laboratory Procedures, most Medicaid payments went to a handful of billing codes.

Looking at percentage shifts, Medicaid payments related to Pathology and Laboratory Procedures in Orange increased by 21% from 2023 to 2024, while all Medicaid claim categories in the city saw a 23.5% increase during the same period.

According to the Centers for Medicare & Medicaid Services, total federal and state Medicaid spending reached about $871.7 billion in fiscal 2023, which was approximately 18% of total national health expenditures. That’s up from $613.5 billion in 2019, prior to the COVID-19 pandemic.

This increase amounts to about 40% over just several years, propelled mostly by greater enrollment and utilization linked to the pandemic period and its aftermath.

Recent federal budget changes under the Trump administration have proposed notable reductions and structural changes for Medicaid. As an example, the “One Big Beautiful Bill Act,” passed into law in 2025, is set to reduce federal Medicaid spending by over $1 trillion in the next 10 years and bring in measures like work requirements and higher cost-sharing that could affect certain beneficiaries by limiting funding and coverage. As a result, these adjustments are expected to move more financial responsibility to states, even as Medicaid remains vital for tens of millions of Americans.

Medicaid Payments Tied to Pathology and Laboratory Procedures in Orange, Texas Over Five Years

Year Total Medicaid Payments % Change From Previous Year
2020 $18,105
2021 $65,699 262.9%
2022 $126,258 92.2%
2023 $123,413 -2.3%
2024 $149,334 21%
Top Categories by Medicaid Payments in Orange, Texas, 2024

Rank Category Medicaid Payments Share of City Total
1 Evaluation and Management $2,818,501 84.8%
2 National Codes Established for State Medicaid Agencies $160,418 4.8%
3 Pathology and Laboratory Procedures $149,334 4.5%
4 Dental Services $127,940 3.9%
5 Medicine Services and Procedures $64,019 1.9%
6 Temporary National Codes (Non-Medicare) $1,505 <0.1%
7 Vision Services $726 <0.1%
8 Procedures / Professional Services $96 <0.1%
9 Surgery $0 <0.1%
Top 20 HCPCS Codes Within the Pathology and Laboratory Procedures Category in Orange, Texas, 2024

HCPCS Code Description Medicaid Payments Claims
87811 Sars-cov-2 covid19 w/optic $55,960 12
87804 Influenza assay w/optic $42,957 19
87880 Strep a assay w/optic $31,916 35
87426 Sarscov coronavirus ag ia $10,581 8
87807 Rsv assay w/optic $6,323 12
81025 Urine pregnancy test $628 5
86580 Tb intradermal test $558 3
83655 Assay of lead $278 3
85018 Hemoglobin $77 3
80307 Drug test prsmv chem anlyzr $52 1

Note: HCPCS codes are included to provide context within the category. The article’s category totals and rankings are based on grouping related services rather than on individual billing codes.

Data for this article comes from the U.S. Department of Health and Human Services Medicaid Provider Spending database, available here.



Related

Brian Babin, Chairman of the Committee on Science, Space, and Technology

House Science Committee leaders seek information on NASEM Attribution Committee policies

Leaders from the House Science Committee have requested detailed information from NASEM about its Attribution Committee amid concerns over potential conflicts of interest. The lawmakers highlighted transparency issues related to committee member affiliations with advocacy groups.

Brian Babin, Chairman of the Committee on Science, Space, and Technology

House Science Committee leaders request information from NASEM on greenhouse gas study

Leaders from three House Science subcommittees have asked NASEM for detailed information regarding its greenhouse gas study process. Their request highlights concerns over transparency, potential conflicts of interest, and adherence to federal advisory standards.

Dade Phelan, Texas State Representative of 21st district

Dade Phelan calls for resignations and comments on Trump’s criticism of Pope Leo XIV

Dade Phelan, Texas state representative since 2015, posted tweets between April 11 and April 13, calling out Rep. Tony Gonzales over ethics allegations and criticizing Donald Trump’s remarks about Pope Leo XIV’s stance on peace regarding Iran.